Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

Jenburkt Pharmaceuticals Limited, a 40-year-old pharmaceutical organization listed on the Bombay Stock Exchange and a pioneer ...

Belgium’s Deputy Prime Minister, Frank Vandenbroucke, called the EU’s joint health technology assessment a model of European cooperation, improving medicine evaluation, reducing costs, and ...

Bhopal: Chief minister Mohan Yadav said on Friday that Madhya Pradesh is emerging as a global hub for industrial investment and strategic innovation.

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...